Sinopharm Tech Holdings Limited reported earnings results for the second quarter and six months ended December 31, 2023. For the second quarter, the company reported sales was HKD 14.85 million compared to HKD 9.4 million a year ago. Net loss was HKD 0.533 million compared to net income of HKD 11.03 million a year ago. Basic loss per share from continuing operations was HKD 0.0029 compared to basic earnings per share from continuing operations of HKD 0.0607 a year ago.
For the six months, sales was HKD 18.84 million compared to HKD 15.03 million a year ago. Net loss was HKD 2.88 million compared to net income of HKD 15.41 million a year ago. Basic loss per share from continuing operations was HKD 0.0157 compared to basic earnings per share from continuing operations of HKD 0.0846 a year ago.